Literature DB >> 34212246

Association of gut microbiomes with lung and esophageal cancer: a pilot study.

Weitao Shen1, Derong Tang2, Yali Deng1, Huilin Li1, Tian Wang1, Ping Wan1, Ran Liu3.   

Abstract

Gut microbiota, especially human pathogens, has been shown to be involved in the occurrence and development of cancer. Esophageal squamous cell carcinoma and lung cancer are two malignant cancers, and their relationship with gut microbiota is still unclear. Virulence factor database (VFDB) is an integrated and comprehensive online resource for curating information about human pathogens. Here, based on VFDB database, we analyzed the differences of bacteria at genus level in the gut of patients with esophageal squamous cell carcinoma, lung cancer, and healthy controls. We proposed the possible cancer-associated bacteria in gut and put forward their possible effects. Apart from this, principal coordinate analysis (PCoA) and analysis of similarities (ANSOIM) suggested that some bacteria in the gut can be used as potential biomarkers to screen esophageal squamous cell carcinoma and lung cancer, and their effectiveness was preliminary verified. The relative abundance of Klebsiella and Streptococcus can be used to distinguish patients with esophageal squamous cell carcinoma and lung cancer from healthy controls. The absolute abundance of Klebsiella can further distinguish patients with esophageal squamous cell carcinoma from patients with lung cancer. In particular, the relative abundance of Fusobacterium can directly distinguish between patients with esophageal squamous cell carcinoma and healthy controls. Additionally, the absolute abundance of Haemophilus can distinguish lung cancer from healthy controls. Our study provided a new way based on VFDB database to explore the relationship between gut microbiota and cancer, and initially proposed a feasible cancer screening method.

Entities:  

Keywords:  Biomarkers; Esophageal cancer; Gut; Lung cancer; Pathogens

Year:  2021        PMID: 34212246     DOI: 10.1007/s11274-021-03086-3

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  38 in total

1.  Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study.

Authors:  James J Goedert; Gieira Jones; Xing Hua; Xia Xu; Guoqin Yu; Roberto Flores; Roni T Falk; Mitchell H Gail; Jianxin Shi; Jacques Ravel; Heather Spencer Feigelson
Journal:  J Natl Cancer Inst       Date:  2015-06-01       Impact factor: 13.506

2.  Identification and Characterization of MicroRNA Differentially Expressed in Macrophages Exposed to Porphyromonas gingivalis Infection.

Authors:  Olivier Huck; Jacob Al-Hashemi; Laetitia Poidevin; Olivier Poch; Jean-Luc Davideau; Henri Tenenbaum; Salomon Amar
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

Review 3.  Gut microbiota and metabolites in the pathogenesis of endocrine disease.

Authors:  Aline C Fenneman; Elena Rampanelli; Yue S Yin; Jesse Ames; Martin J Blaser; Eric Fliers; Max Nieuwdorp
Journal:  Biochem Soc Trans       Date:  2020-06-30       Impact factor: 5.407

4.  Redefined duplex ultrasonographic criteria for diagnosis of carotid artery stenosis.

Authors:  J Huston; E M James; R D Brown; R D Lefsrud; D M Ilstrup; E F Robertson; F B Meyer; J W Hallett
Journal:  Mayo Clin Proc       Date:  2000-11       Impact factor: 7.616

5.  Global incidence of oesophageal cancer by histological subtype in 2012.

Authors:  Melina Arnold; Isabelle Soerjomataram; Jacques Ferlay; David Forman
Journal:  Gut       Date:  2014-10-15       Impact factor: 23.059

6.  Intestinal inflammation targets cancer-inducing activity of the microbiota.

Authors:  Janelle C Arthur; Ernesto Perez-Chanona; Marcus Mühlbauer; Sarah Tomkovich; Joshua M Uronis; Ting-Jia Fan; Barry J Campbell; Turki Abujamel; Belgin Dogan; Arlin B Rogers; Jonathan M Rhodes; Alain Stintzi; Kenneth W Simpson; Jonathan J Hansen; Temitope O Keku; Anthony A Fodor; Christian Jobin
Journal:  Science       Date:  2012-08-16       Impact factor: 47.728

7.  Microbiota modulate tumoral immune surveillance in lung through a γδT17 immune cell-dependent mechanism.

Authors:  Min Cheng; Liting Qian; Guodong Shen; Geng Bian; Tingjuan Xu; Weiping Xu; Gan Shen; Shilian Hu
Journal:  Cancer Res       Date:  2014-06-19       Impact factor: 12.701

Review 8.  Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications.

Authors:  Yoshifumi Baba; Masaaki Iwatsuki; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  Ann Gastroenterol Surg       Date:  2017-06-07

9.  Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin.

Authors:  Zhen He; Raad Z Gharaibeh; Rachel C Newsome; Jllian L Pope; Michael W Dougherty; Sarah Tomkovich; Benoit Pons; Gladys Mirey; Julien Vignard; David R Hendrixson; Christian Jobin
Journal:  Gut       Date:  2018-10-30       Impact factor: 23.059

View more
  1 in total

1.  Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion.

Authors:  Ningning Zhang; Zeyu Wang; Jiayu Lv; Shuwen Zhang; Yang Liu; Tian Liu; Wang Li; Lan Gong; Xiaodong Zhang; Emad M El-Omar; Wei Lu
Journal:  Front Med (Lausanne)       Date:  2022-03-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.